These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7559187)

  • 1. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.
    Smith MA; Edwards DI
    J Antimicrob Chemother; 1995 Jun; 35(6):751-64. PubMed ID: 7559187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori.
    Smith MA; Edwards DI
    J Antimicrob Chemother; 1997 Mar; 39(3):347-53. PubMed ID: 9096184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mode of action of metronidazole in Helicobacter pylori: futile cycling or reduction?
    Jorgensen MA; Manos J; Mendz GL; Hazell SL
    J Antimicrob Chemother; 1998 Jan; 41(1):67-75. PubMed ID: 9511039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori.
    Smith MA; Edwards DI
    J Antimicrob Chemother; 1995 Sep; 36(3):453-61. PubMed ID: 8830009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.
    Goodwin A; Kersulyte D; Sisson G; Veldhuyzen van Zanten SJ; Berg DE; Hoffman PS
    Mol Microbiol; 1998 Apr; 28(2):383-93. PubMed ID: 9622362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori.
    van der Wouden EJ; Thijs JC; Kusters JG; van Zwet AA; Kleibeuker JH
    Scand J Gastroenterol Suppl; 2001; (234):10-4. PubMed ID: 11768554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed mechanism for metronidazole resistance in Helicobacter pylori.
    Cederbrant G; Kahlmeter G; Ljungh A
    J Antimicrob Chemother; 1992 Feb; 29(2):115-20. PubMed ID: 1506325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation.
    Mégraud F; Occhialini A; Doermann HP
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():25-38. PubMed ID: 9440053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on metronidazole: an old warhorse in antimicrobial chemotherapy.
    Leitsch D
    Parasitology; 2019 Aug; 146(9):1167-1178. PubMed ID: 29166971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
    Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS
    J Gastroenterol; 1998; 33 Suppl 10():62-5. PubMed ID: 9840021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.
    Hoffman PS; Goodwin A; Johnsen J; Magee K; Veldhuyzen van Zanten SJ
    J Bacteriol; 1996 Aug; 178(16):4822-9. PubMed ID: 8759844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
    Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J
    J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of Helicobacter pylori isolates under microaerophilic atmospheres established by two different methods.
    Kobayashi I; Muraoka H; Saika T; Nishida M; Fujioka T; Nasu M
    J Clin Microbiol; 2001 Jul; 39(7):2646-7. PubMed ID: 11427585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in Helicobacter pylori: a global overview.
    Glupczynski Y
    Acta Gastroenterol Belg; 1998; 61(3):357-66. PubMed ID: 9795473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
    Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lon protease affects the RdxA nitroreductase activity and metronidazole susceptibility in Helicobacter pylori.
    Tu IF; Liao JH; Yang FL; Lin NT; Chan HL; Wu SH
    Helicobacter; 2014 Oct; 19(5):356-66. PubMed ID: 24834789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori.
    Kaihovaara P; Höök-Nikanne J; Uusi-Oukari M; Kosunen TU; Salaspuro M
    J Antimicrob Chemother; 1998 Feb; 41(2):171-7. PubMed ID: 9533458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs.
    Rao DN; Mason RP
    J Biol Chem; 1987 Aug; 262(24):11731-6. PubMed ID: 2887562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: nitroimidazole resistance in Helicobacter pylori.
    Van Der Wouden EJ; Thijs JC; Van Zwet AA; Kleibeuker JH
    Aliment Pharmacol Ther; 2000 Jan; 14(1):7-14. PubMed ID: 10632640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori.
    Lacey SL; Moss SF; Taylor GW
    J Antimicrob Chemother; 1993 Sep; 32(3):393-400. PubMed ID: 8262861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.